In the perpetual pursuit of a more efficient clinical research process, biopharmaceutical sponsors and contract research organizations (CROs) have traditionally focused their resources on the more costly and time-consuming aspects of study start-up such as protocol development, regulatory and ethical review, and data management and analysis. Investigator site contracting and management of site payments are often overlooked as opportunities to accelerate study start-up and to reduce the expense and complications of managing study site contractual relationships.
However, by targeting this smaller, yet still significant, aspect of study start-up, sponsors and CROs can expedite the process of contract negotiation, reducing both the cycle time and burden on the legal infrastructure.
Download this whitepaper to learn more.
Speak With Our Experts